Geode Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.6M Buy
2,333,213
+341,039
+17% +$10.1M ﹤0.01% 1539
2025
Q4
$62M Buy
1,992,174
+225,987
+13% +$6.2M ﹤0.01% 1360
2025
Q3
$38.1M Buy
1,766,187
+25,573
+1% +$461K ﹤0.01% 1659
2025
Q2
$24.3M Buy
1,740,614
+20,089
+1% +$273K ﹤0.01% 1859
2025
Q1
$23.2M Buy
1,720,525
+61,545
+4% +$1.05M ﹤0.01% 1823
2024
Q4
$31.8M Buy
1,658,980
+165,669
+11% +$3.6M ﹤0.01% 1699
2024
Q3
$34M Buy
1,493,311
+81,951
+6% +$1.34M ﹤0.01% 1673
2024
Q2
$18.4M Buy
1,411,360
+247,088
+21% +$3.42M ﹤0.01% 1975
2024
Q1
$20.4M Buy
1,164,272
+169,804
+17% +$3.29M ﹤0.01% 1912
2023
Q4
$21.7M Buy
994,468
+135,373
+16% +$2.14M ﹤0.01% 1860
2023
Q3
$13.2M Sell
859,095
-1,762
-0.2% -$33.6K ﹤0.01% 2086
2023
Q2
$20.5M Buy
860,857
+84,745
+11% +$2.17M ﹤0.01% 1841
2023
Q1
$19.7M Buy
776,112
+65,127
+9% +$2.09M ﹤0.01% 1812
2022
Q4
$20.8M Buy
710,985
+111,219
+19% +$2.56M ﹤0.01% 1751
2022
Q3
$12.3M Buy
599,766
+150,106
+33% +$2.7M ﹤0.01% 2088
2022
Q2
$5.2M Buy
449,660
+250,422
+126% +$3.37M ﹤0.01% 2678
2022
Q1
$3.68M Sell
199,238
-2,440
-1% -$46.9K ﹤0.01% 2961
2021
Q4
$3.99M Buy
201,678
+140,428
+229% +$2.62M ﹤0.01% 3020
2021
Q3
$1.01M Buy
61,250
+22,967
+60% +$337K ﹤0.01% 3671
2021
Q2
$700K Buy
38,283
+15,389
+67% +$263K ﹤0.01% 3777
2021
Q1
$382K Buy
22,894
+7,219
+46% +$135K ﹤0.01% 3900
2020
Q4
$257K Sell
15,675
-1,883
-11% -$28.4K ﹤0.01% 3808
2020
Q3
$204K Buy
17,558
+5,802
+49% +$86.5K ﹤0.01% 3711
2020
Q2
$195K Buy
11,756
+1,441
+14% +$16.4K ﹤0.01% 3670
2020
Q1
$69K Hold
10,315
﹤0.01% 3859
2019
Q4
$74K Hold
10,315
﹤0.01% 4026
2019
Q3
$113K Sell
10,315
-76
-0.7% -$1.68K ﹤0.01% 3921
2019
Q2
$319K Sell
10,391
-5,693
-35% -$229K ﹤0.01% 3632
2019
Q1
$673K Buy
16,084
+742
+5% +$33.6K ﹤0.01% 3313
2018
Q4
$697K Buy
15,342
+770
+5% +$44.5K ﹤0.01% 3247
2018
Q3
$1.22M Buy
14,572
+631
+5% +$59.5K ﹤0.01% 3132
2018
Q2
$1.34M Buy
13,941
+7,166
+106% +$758K ﹤0.01% 3060
2018
Q1
$712K Buy
6,775
+610
+10% +$66.3K ﹤0.01% 3278
2017
Q4
$964K Buy
6,165
+538
+10% +$68.5K ﹤0.01% 3119
2017
Q3
$772K Buy
5,627
+3,572
+174% +$601K ﹤0.01% 3209
2017
Q2
$398K Buy
2,055
+1,258
+158% +$212K ﹤0.01% 3435
2017
Q1
$148K Buy
+797
New +$137K ﹤0.01% 3740

Other funds holding VRDN